2022 Seminar Weekend – topic
Racial inequities in medication use
Two national pandemics – COVID-19 and racism – have highlighted inequities in medication use in the United States. These inequities often translate to poorer health outcomes in communities that already have barriers to optimal health. While the evidence documenting these disparities is abundant, systemic solutions remain elusive. This seminar will focus on #pharmacoequity and how pharmacists can help bring an end to health disparities.
Overview
The 28th Pharmaceutical Outcomes and Policy seminar will examine how optimal medication use differs by race and ethnicity and what underlying factors confound this relationship. Experts will discuss imperatives for increasing diversity in clinical trials, removing access barriers, and enhancing data and measures. Finally, industry leaders will share examples of incremental progress made through real-world programs and propose systemic strategies to combat racial inequities in medication use.
Logistics
Location: Seminar will be held virtually this year – please register below.
Dates: March 5-6, 2022
When: 11 – 1:15 p.m.; 2:30 – 4 p.m. EST
Speakers
Keynote Speaker | "Pursuing pharmacoequity: Race and novel drugs in the US"
Utibe R. Essien, MD, MPH
Assistant Professor of Medicine University of Pittsburgh School of Medicine
Speaker | “Structural racism and pharmacy deserts”
Dima Qato, Pharm.D., MPH, Ph.D.
Senior Fellow, University of Southern California (USC) Schaeffer Center
Hygeia Centennial Chair and Associate Professor, USC School of Pharmacy
SPEAKER | “Bridging the Gap between Social Inequities and Cost Effectiveness Analyses”
Jacquelyn McRae, Pharm.D., M.S.
Director, Policy, Research and Membership
PhRMA
Speaker | “Medicaid policies that promote health equity in the delivery of pharmacy services”
John Coster, Ph.D., R.Ph.
Director, Division of Pharmacy
Center for Medicaid and CHIP
Center for Medicare and Medicaid Services
Speaker | “Increasing diversity in clinical trials and the role of HEOR”
Kim Ribeiro, MLS (ASCP)CM, M.S.
Director, Diversity & Patient Inclusion
AbbVie
SPEAKER | “INCREASING DIVERSITY IN CLINICAL TRIALS AND THE ROLE OF HEOR”
Sudeep Karve, Ph.D., M.S., B.Pharm.
Therapeutic Lead, Imbruvica and Solid Tumors
AbbVie
SPEAKER | “A research program examining racial/ethnic disparities in Medicare MTM services”
Junling Wang, Ph.D.
Professor and Vice Chair for Research
Department of Clinical Pharmacy and Translational Science
University of Tennessee College of Pharmacy
SPEAKER | “Advancing health equity through quality measurement”
Micah Cost, Pharm.D., M.S.
CEO, Pharmacy Quality Alliance
Speaker | “Learning from COVID-19: A path towards health equity”
John Allen, Pharm.D. BCPS BCCP, FCCM, FCCP
Associate Dean for Diversity, Inclusion and Health Equity
University of Florida, College of Pharmacy